The conflict in Yemen is creating a dire situation in the country, making everyday life a challenge for its citizens. Among the most vulnerable people in the country are those with a bleeding disorder.
The World Federation of Hemophilia (WFH) Humanitarian Aid Program is doing its very best to support the community in Yemen. Factor donations must usually be coordinated through a country’s national member association (NMO), and unfortunately, Yemen does not have an NMO. Luckily, a physician in the country named Rajaa who has a child with hemophilia reached out to the WFH for help and was able to make an introduction. Through her initiative, the WFH has been able to find someone who could support the process for getting donations into the country: Mohammed Morish, MD, a physician who works at Al Thawra Modern General Hospital (TMGH) in Sanaa, the capital and largest city of Yemen. Since the WFH needs to liaise with a hospital in order to ship donated factor, Morish has become the main contact for factor donations in the Middle Eastern nation.
Due to the challenging conditions in Yemen, the WFH has only been able to send a modest amount of factor to the country. Fortunately, Morish has been very diligent and careful with the donations he has received. By using the factor strategically, he has been able to help a number of patients. Stories like these show how the WFH Humanitarian Aid Program can work with committed individuals to make a difference in local communities.
About the WFH Humanitarian Aid Program
The expanded WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Visionary Contributors; Grifols, CSL Behring, GC Pharma, our Corporate partners; and Roche and Bayer, our newest donors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.